Email UpdatesThis document summarizes a discussion from a workshop where experts examined the evidence for candidate endpoints and study design strategies for clinical trials of stimulant use disorder treatments.
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
File Size
674 KB
Year
Format
Terms of Use
Topic
Resource Type
Special Collection